Search

Your search keyword '"symptomatic vitreomacular adhesion"' showing total 15 results

Search Constraints

Start Over You searched for: Descriptor "symptomatic vitreomacular adhesion" Remove constraint Descriptor: "symptomatic vitreomacular adhesion"
15 results on '"symptomatic vitreomacular adhesion"'

Search Results

1. Retrospective Study of Ellipsoid Zone Integrity Following Treatment with Intravitreal Ocriplasmin (OZONE Study)

2. Prognostic Factors Associated with Ocriplasmin Efficacy for the Treatment of Symptomatic Vitreomacular Adhesion and Full-thickness Macular Hole: Analysis from Four Studies

Catalog

Books, media, physical & digital resources

3. Patient-reported outcomes of ocriplasmin for the treatment of vitreomacular traction: a systematic review and synthesis of the literature

4. Prognostic Factors Associated with Ocriplasmin Efficacy for the Treatment of Symptomatic Vitreomacular Adhesion and Full-thickness Macular Hole: Analysis from Four Studies.

5. OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE

6. Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole.

7. Retrospective study of ellipsoid zone integrity following treatment with intravitreal ocriplasmin (OZONE Study)

8. Autolytic degradation of ocriplasmin: a complex mechanism unraveled by mutational analysis.

9. Mechanism of inactivation of ocriplasmin in porcine vitreous

10. PATIENT-REPORTED VISUAL FUNCTION FROM THE OCRIPLASMIN FOR TREATMENT FOR SYMPTOMATIC VITREOMACULAR ADHESION, INCLUDING MACULAR HOLE (OASIS) STUDY

11. Visual function response to ocriplasmin for the treatment of vitreomacular traction and macular hole

12. Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole

13. Cost-effectiveness analysis of ocriplasmin versus watchful waiting for treatment of symptomatic vitreomacular adhesion in the US.

14. Mechanism of inactivation of ocriplasmin in porcine vitreous

15. The Ocriplasmin for Vitreomacular Traction Intravitreal Injection Decisions (OVIID-I) Trial: Full Study Results.